Europe • Frankfurt Stock Exchange • FRA:AFX • DE0005313704
The current stock price of AFX.DE is 27.04 EUR. In the past month the price decreased by -34.4%. In the past year, price decreased by -51.95%.
ChartMill assigns a fundamental rating of 5 / 10 to AFX.DE. Both the profitability and the financial health of AFX.DE get a neutral evaluation. Nothing too spectacular is happening here.
Over the last trailing twelve months AFX.DE reported a non-GAAP Earnings per Share(EPS) of 1.61. The EPS decreased by -19.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 6.34% | ||
| ROA | 4.15% | ||
| ROE | 6.67% | ||
| Debt/Equity | 0.27 |
22 analysts have analysed AFX.DE and the average price target is 49.78 EUR. This implies a price increase of 84.08% is expected in the next year compared to the current price of 27.04.
For the next year, analysts expect an EPS growth of 20.35% and a revenue growth 4.23% for AFX.DE
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 2M6 | MEDTRONIC PLC | 16.87 | 113.317B | ||
| 1MDT | MEDTRONIC PLC | 16.13 | 108.304B | ||
| SHL | SIEMENS HEALTHINEERS AG | 17.29 | 48.053B | ||
| 1PHIA | KONINKLIJKE PHILIPS NV | 16.27 | 23.842B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 16.13 | 23.669B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 15.88 | 23.264B | ||
| BIM | BIOMERIEUX | 19.23 | 11.54B | ||
| DIA | DIASORIN SPA | 18.12 | 4.173B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 19.61 | 3.916B | ||
| 1AFX | CARL ZEISS MEDITEC AG - BR | 14.5 | 2.513B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.
CARL ZEISS MEDITEC AG - BR
Goeschwitzer Strasse 51-52
Jena THUERINGEN DE
Employees: 5730
Phone: 493641220331
Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. The company is headquartered in Jena, Thueringen and currently employs 5,784 full-time employees. The company went IPO on 2000-03-20. The firm offers complete solutions to diagnose and treat ophthalmic diseases, visualization solutions for microsurgery and other technologies, such as intraoperative radiotherapy. The firm operates in two segments: ophthalmic devices and microsurgery. The Ophthalmic Devices segment comprises activities in ophthalmology, such as intraocular lenses, surgical visualization solutions and medical laser and diagnostic systems. The Microsurgery segment includes activities of neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiation. Its products include zeiss corneal photographers, slit lamps and accessories, data management software, zeiss intraocular lenses, optical biometers, optical coherence tomography systems, ophthalmic microscopes, refractive lasers are among others. The firm offers related support services.
The current stock price of AFX.DE is 27.04 EUR. The price decreased by -1.1% in the last trading session.
CARL ZEISS MEDITEC AG - BR (AFX.DE) has a dividend yield of 1.96%. The yearly dividend amount is currently 0.6.
AFX.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AFX.DE.
CARL ZEISS MEDITEC AG - BR (AFX.DE) has a market capitalization of 2.42B EUR. This makes AFX.DE a Mid Cap stock.